$0.0376
0.0001[0.27%]
At close: Apr 25
Navidea Biopharmaceutical
(OTCPK:NAVB)Navidea Biopharmaceutical Stock (OTC:NAVB), Analyst Ratings, Price Targets, Predictions
Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Analyst Ratings for Navidea Biopharmaceutical
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Navidea Biopharmaceutical (NAVB)?
There is no price target for Navidea Biopharmaceutical.
What is the most recent analyst rating for Navidea Biopharmaceutical (NAVB)?
There is no analyst for Navidea Biopharmaceutical.
When was the last upgrade for Navidea Biopharmaceutical (NAVB)?
There is no last upgrade for Navidea Biopharmaceutical.
When was the last downgrade for Navidea Biopharmaceutical (NAVB)?
There is no last downgrade for Navidea Biopharmaceutical.
When is the next analyst rating going to be posted or updated for Navidea Biopharmaceutical (NAVB)?
There is no next analyst rating for Navidea Biopharmaceutical.
Is the Analyst Rating Navidea Biopharmaceutical (NAVB) correct?
There is no next analyst rating for Navidea Biopharmaceutical.
Browse analyst ratings and price targets on all stocks.